A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women

NCT00000864 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Abacavir sulfate
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]